Advanced Search

Technical Analysis for CYTH - Cyclo Therapeutics, Inc.

Grade Last Price % Change Price Change
D 5.7 2.89% 0.16
CYTH closed up 2.89 percent on Friday, January 15, 2021, on 13 percent of normal volume.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A N/A Up
Historical CYTH trend table...
Date Alert Name Type % Chg
New Uptrend Bullish 0.00%
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Wide Bands Range Expansion 2.89%
Up 3 Days in a Row Strength 2.89%
20 DMA Support Bullish 13.32%
Calm After Storm Range Contraction 13.32%
Wide Bands Range Expansion 13.32%
20 DMA Support Bullish 17.53%
Older End-of-Day Signals for CYTH ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 3% 2 days ago
Up 2% 2 days ago
60 Minute Opening Range Breakout 2 days ago
Down 5% 2 days ago
Down 3% 2 days ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators Basic chart:

Profile

  • Earnings date: ???
Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C and Alzheimer’s Disease. The company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is the subject of three ongoing formal clinical trials for Niemann-Pick Disease Type C, a rare and fatal genetic disease. The company is planning an early phase clinical trial using Trappsol Cyclo intravenously in Alzheimer’s Disease based on encouraging data from an Expanded Access program for late-onset Alzheimer’s Disease. Additional indications for the active ingredient in Trappsol Cyclo are in development.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Clinical Medicine Rare Diseases Alzheimer's Disease Lipid Storage Disorders

Is CYTH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Jan 5 Why Cyclo, Vivos Therapeutics And More Are Moving Today
Jan 5 Cyclo Therapeutics' lead candidate shows durable benefit in Niemann-Pick Disease
Jan 5 Cyclo Therapeutics Announces Positive Efficacy Data from Extension Protocol with Trappsol® Cyclo™ in Patients with Niemann-Pick Disease Type C
Dec 22 Cyclo Therapeutics Announces Closing of Underwriters’ Option to Purchase Additional Shares of Common Stock in Connection with its Underwritten Public Offering
Dec 21 78 Biggest Movers From Friday
Dec 12 What Can We Learn About Cyclo Therapeutics' (NASDAQ:CYTH) CEO Compensation?
See more CYTH news...

Indicators

Indicator Value
52 Week High 8.73
52 Week Low 3.55
Average Volume 2,608,216
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 5.04
10-Day Moving Average 5.02
Average True Range 0.71
ADX 47.94
+DI 40.89
-DI 11.38
Chandelier Exit (Long, 3 ATRs ) 6.60
Chandelier Exit (Short, 3 ATRs ) 5.70
Upper Bollinger Band 6.12
Lower Bollinger Band 3.95
Percent B (%b) 0.81
BandWidth 43.18
MACD Line 0.20
MACD Signal Line 0.08
MACD Histogram 0.1231
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.53
Resistance 3 (R3) 6.45 6.11 6.39
Resistance 2 (R2) 6.11 5.90 6.14 6.34
Resistance 1 (R1) 5.90 5.77 6.01 5.98 6.30
Pivot Point 5.56 5.56 5.61 5.59 5.56
Support 1 (S1) 5.35 5.35 5.46 5.43 5.10
Support 2 (S2) 5.01 5.22 5.04 5.06
Support 3 (S3) 4.80 5.01 5.01
Support 4 (S4) 4.88